Management Board
Since its founding, CSI Singapore’s strategic direction is strongly guided by the Management Board. With extensive academic, business and leadership experience, Board members oversee the institute’s affairs, steering its long-term strategic direction and conducting reviews on the effectiveness of existing policies. They also manage the institute’s risk, accountability and overall financial programs.
The Management Board of CSI Singapore provides strategic direction to the organization, manages risk and accountability and reviews governance arrangements in steering the Institute towards its vision. There are 7 members as follows:
Chairman
Prof Chong Yap Seng
Lien Ying Chow Professor in Medicine
Dean, Yong Loo Lin School of Medicine
National University of Singapore
Members
Prof Barry Halliwell
Senior Advisor (Academic Appointments and Research Excellence), Office of the Provost, National University of Singapore
Distinguished Professor, Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore
Distinguished Professor, Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore
Prof David Virshup
Director of Programme in Cancer and Stem Cell Biology
Duke-NUS Medical School
Duke-NUS Medical School
Prof Thorsten Wohland
Director, Office of Deputy President (Research & Technology)
National University of Singapore
National University of Singapore
Prof Yeoh Khay Guan
Senior Vice President of Health Affairs
Kishore Mahbubani Professor in Medicine and Health Policy
Kishore Mahbubani Professor in Medicine and Health Policy
Dr Karl Ziegelbauer
Chief Scientific Officer Almirall
Prof Ashok Venkitaraman (ex-officio)
Distinguished Professor, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore
CSI Corporate Video
CSI Virtual Tour
